Choksi Laboratories (CHOKSILA) | Stock Overview & Key Data
Choksi Laboratories Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹236.70 on August 20, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Choksi Laboratories
CHOKSILA
|
703.84M Small-cap | -7.99% | 21.15% | 31.75% | -6.05% | -3.17% | 12.14% | 183.17% | 859.21% | 968.12% | 807.14% | 566.67% |
|
Dr. Lal PathLabs
LALPATHLAB
|
238.92B Large-cap | -2.94% | -0.24% | 15.45% | 4.81% | 3.96% | 15.37% | 59.53% | 12.09% | 223.97% | 258.78% | 258.78% |
|
Sai Life Sciences
SAILIFE
|
217.06B Large-cap | 0.57% | 5.18% | 13.28% | 30.48% | 26.38% | 53.25% | 64.85% | 64.85% | 64.85% | 64.85% | 64.85% |
|
Vimta Labs
VIMTALABS
|
20.49B Small-cap | 12.38% | 7.74% | 19.25% | -16.12% | -14.67% | -4.01% | 127.88% | 285.95% | 1,215.69% | 2,521.09% | 343.62% |
|
Krsnaa Diagnostics
KRSNAA
|
19.83B Small-cap | 0.47% | -8.16% | -10.16% | -29.42% | -26.94% | -14.17% | -2.87% | -40.72% | -40.72% | -40.72% | -40.72% |
|
Suraksha Diagnostic
SURAKSHA
|
14.71B Small-cap | 0.57% | 2.39% | 7.99% | 4.09% | 6.63% | -10.99% | -31.50% | -31.50% | -31.50% | -31.50% | -31.50% |
Ownership & Short Interest
Calculate Your Choksi Laboratories Investment Returns
Long-Term Investment Performance Analysis
Choksi Laboratories stock price in May 2016 was ₹11.89, A ₹1,000.00 lump sum investment in Choksi Laboratories made 10 years ago would be worth approximately ₹10,550.88 today, representing a exceptional return of 955.09%. This translates to an annualized return (CAGR) of 26.53%.
10 Years Investment Scenario (May 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is CHOKSILA's 52-week high and low?
- In the last 52 weeks, Choksi Laboratories reached a high of ₹236.70 (on August 20, 2025) and a low of ₹81.85 (on March 4, 2026).
- What is the market cap and P/E ratio for CHOKSILA?
- Curious about Choksi Laboratories's size and valuation? Its market capitalization stands at 703.84M. When it comes to valuation, the P/E ratio (trailing twelve months) is 37.71, and the forward P/E (looking ahead) is N/A.
- Does CHOKSILA pay dividends? If so, what's the yield?
- As for dividends, Choksi Laboratories isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Choksi Laboratories's main competitors or similar companies to consider before investing?
When looking at Choksi Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Dr. Lal PathLabs
LALPATHLAB238.92B Healthcare Diagnostics & Research 15.37% 59.53% Sai Life Sciences
SAILIFE217.06B Healthcare Diagnostics & Research 53.25% 64.85% Vimta Labs
VIMTALABS20.49B Healthcare Diagnostics & Research -4.01% 127.88% Krsnaa Diagnostics
KRSNAA19.83B Healthcare Diagnostics & Research -14.17% -2.87% Suraksha Diagnostic
SURAKSHA14.71B Healthcare Diagnostics & Research -10.99% -31.50% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Choksi Laboratories Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Choksi Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.45%, the Debt to Equity ratio from the most recent quarter is 120.16, and its Gross Profit Margin stands at 80.48%.
- What is the recent revenue and earnings growth for CHOKSILA?
- Looking at Choksi Laboratories's growth, its revenue over the trailing twelve months (TTM) was INR446M. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.30%, and quarterly earnings saw a YoY growth of 193.40%.
- How much of CHOKSILA stock is held by insiders and institutions?
- Wondering who owns Choksi Laboratories stock? Company insiders (like executives and directors) hold about 60.49% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.